Literature DB >> 2224803

Familial testicular cancer in five members of a cancer-prone kindred.

P E Goss1, M A Bulbul.   

Abstract

Of a family of 13 siblings, four brothers have developed testicular neoplasms, one embryonal cell carcinoma and three testicular seminomas. A first cousin once removed on their mother's side of the family (fourth-degree relative) has developed an embryonal carcinoma. After treatment they are all alive and well. Their mother is a dizygous twin and one of ten siblings. Multiple other cancers have been diagnosed among her siblings and their offspring including breast carcinoma at age 30 years in monozygous twin nieces. Associated urogenital abnormalities, concordance of age, and discordance of pathology in the five males with testicular cancer is discussed. Further identification and reporting of this risk factor is encouraged.

Entities:  

Mesh:

Year:  1990        PMID: 2224803     DOI: 10.1002/1097-0142(19901101)66:9<2044::aid-cncr2820660933>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Familial testicular cancer. What role does heredity play?

Authors:  J Douketis; R L Burkes
Journal:  Can Fam Physician       Date:  1993-07       Impact factor: 3.275

2.  Familial/bilateral and sporadic testicular germ cell tumors show frequent genetic changes at loci with suggestive linkage evidence.

Authors:  R I Skotheim; S M Kraggerud; S D Fosså; A E Stenwig; T Gedde-Dahl ; H E Danielsen; K S Jakobsen; R A Lothe
Journal:  Neoplasia       Date:  2001 May-Jun       Impact factor: 5.715

3.  Clinical and genetic aspects of testicular germ cell tumours.

Authors:  Martijn F Lutke Holzik; Rolf H Sijmons; Josette Ehm Hoekstra-Weebers; Dirk T Sleijfer; Harald J Hoekstra
Journal:  Hered Cancer Clin Pract       Date:  2008-02-15       Impact factor: 2.857

4.  Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis.

Authors:  D Forman; R T Oliver; A R Brett; S G Marsh; J H Moses; J G Bodmer; C E Chilvers; M C Pike
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.